LENZ in the 13F filings
Lenz Therapeutics Inc · CUSIP 52635N103
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 15 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 17
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 1 listed it in both
- Shares listed
- 7,425,689
- combined, among listed positions
- Reported value
- $68m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 10 buyers (opened or added shares) and 9 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +596,535.
Managers listing LENZ in Q1 2026
17 of 17 holders
Largest increases and reductions, by shares
Increases
- Squarepoint Ops LLCexisting position · 1,506,499 shares now+1,014,601
- Millennium Management LLCexisting position · 869,257 shares now+329,909
- Two Sigma Investments LPexisting position · 500,997 shares now+207,551
- AQR Capital Management LLCnew position · 140,305 shares now+140,305
- Marshall Wace LLPexisting position · 160,264 shares now+125,012
Reductions
- T. Rowe Price Associates Incexisting position · 39,621 shares now-983,921
- Fidelity (FMR LLC)existing position · 3,597,784 shares now-104,934
- Freestone Grove Partners LPexisting position · 2 shares now-22,969
- Brevan Howard Capital Management LPexisting position · 13,570 shares now-1,838
New positions and exits
New (3)
Exited (5)
- Citadel Advisors LLCwas $1.3m
- Wellington Management Group LLPwas $870k
- Jane Street Group LLCwas $750k
- Verition Fund Management LLCwas $740k
- Quantbot Technologies LPwas $270k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2024 | 1 | $19m | 1 | 0 |
| Q2 2024 | 1 | $15m | 0 | 0 |
| Q3 2024 | 1 | $21m | 0 | 0 |
| Q4 2024 | 1 | $23m | 0 | 1 |
| Q1 2025 | 1 | $22m | 1 | 0 |
| Q4 2025 | 1 | $3.9m | 16 | 9 |
| Q1 2026 | 1 | $2.2m | 10 | 9 |
| Q2 2026 | 1 | $1.4m | 11 | 6 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LENZ and GILD →LENZ and AMGN →LENZ and ARGX →Choose a stock to compare with LENZ →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LENZ, latest filings →Back to the 13F Explorer →